Condition (MeSH)
Paralysis, Hyperkalemic Periodic
ClinicalTrials.gov lists 5 trials for Paralysis, Hyperkalemic Periodic or a narrower condition beneath it. National Center for Research Resources (NCRR) has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Paralysis, Hyperkalemic Periodic itself; the rest are tagged with a narrower condition beneath it.
When did Paralysis, Hyperkalemic Periodic trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Not applicable
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2022 | 1 |
| 2013 | 1 |
| 2007 | 1 |
| 1992 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Paralysis, Hyperkalemic Periodic trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 3 |
| Not applicable | 2 |
How many Paralysis, Hyperkalemic Periodic trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 3 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Paralysis, Hyperkalemic Periodic trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 1 |
Which serious adverse events do Paralysis, Hyperkalemic Periodic trials report? (6)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Adenocarcinoma | 1 | 1 |
| Cauda equina syndrome | 1 | 1 |
| Humerus fracture | 1 | 1 |
| Rash | 1 | 1 |
| Road traffic accident | 1 | 1 |
Showing 5 of 6 adverse events.
Which publications cover Paralysis, Hyperkalemic Periodic? (1)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Transdermal rotigotine for the perioperative management of restless legs syndrome. | BMC neurology | 2012 | No |
Prevalence (9)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Hyperkalemic periodic paralysis | Point prevalence | 1-9 / 1 000 000 | United Kingdom | GB | Exact |
| Hyperkalemic periodic paralysis | Point prevalence | 1-9 / 1 000 000 | United Kingdom | GB | Unspecified |
| Hyperkalemic periodic paralysis | Point prevalence | 1-9 / 1 000 000 | United Kingdom | GB | Exact |
| Hyperkalemic periodic paralysis | Point prevalence | <1 / 1 000 000 | Netherlands | Not stated | Exact |
| Hyperkalemic periodic paralysis | Point prevalence | 1-9 / 1 000 000 | Europe | Not stated | Exact |
Showing 5 of 9 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Hyperkalemic periodic paralysis | 682 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Hyperkalemic periodic paralysis | 682 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.